Home › Asthma › South Carolina
Asthma clinical trials in South Carolina
9 studies for Asthma are looking for participants at sites in South Carolina.
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Spartanburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Charleston
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 30, 2026 · NCT05757102Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Rock Hill
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, North Charleston
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT07301255A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 16, Rock Hill
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Sep 22, 2026 · NCT07359846A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research of Rock Hill, Rock Hill
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT06977581A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12107, Rock Hill
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 31, 2026 · NCT06664619Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Charleston
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Aug 13, 2026 · NCT06307665A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Rock Hill
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07532265From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.